Chuck McElhinny

Mr. Chuck McElhinny

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
CMChuck McElhinny
Chuck McElhinny
ALAnita H. Lewin
Anita H. Lewin
SMS. Wayne Mascarella
S. Wayne Mascarella
SRScott Runyon
Scott Runyon
LBLawrence Brieaddy
Lawrence Brieaddy
FCF. Ivy Carroll
F. Ivy Carroll

1 August 2003 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
JWJared M. Wagner
Jared M. Wagner
CMChuck McElhinny
Chuck McElhinny
ALAnita H. Lewin
Anita H. Lewin
FCF.Ivy Carroll
F.Ivy Carroll

4 November 2011 in Synthesis
Verified
Journal Article
Closed access
PDF file
ALAnita H. Lewin
Anita H. Lewin
CMChuck McElhinny
Chuck McElhinny
FCF. I. Carroll
F. I. Carroll
The orally active, noncompetitive, selective AMPA receptor antagonist Perampanel, 2-[1′,6′-dihydro-6′-oxo-1-phenyl-(2′,3′-bipyridin)-5′-yl]benzonitrile, has been prepared from readily available, relatively inexpensive starting materials. The synthesis was carried out on a laboratory scale with no specialized equipment, and involved only two chromatographic purifications.

30 September 2015 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
SCSteven D. Chang
Steven D. Chang
LBLawrence E. Brieaddy
Lawrence E. Brieaddy
JHJoseph D. Harvey
Joseph D. Harvey
ALAnita H. Lewin
Anita H. Lewin
SMS. Wayne Mascarella
S. Wayne Mascarella
FCF. Ivy Carroll
F. Ivy Carroll

15 July 2009 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
PLPamela B. Lamb
Pamela B. Lamb
CMChuck McElhinny
Chuck McElhinny
TSTodd Sninski
Todd Sninski
HPHunter Purdom
Hunter Purdom
FCF. Ivy Carroll
F. Ivy Carroll
ALAnita H. Lewin
Anita H. Lewin

6 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AZAllison Zarkin
Allison Zarkin
RJRajwana Jahan
Rajwana Jahan
RURajendra Uprety
Rajendra Uprety
YZYanan Zhang
Yanan Zhang
CMChuck McElhinny
Chuck McElhinny
SRscott runyon
scott runyon
Activation of the neuropeptide S receptor (NPSR) system has been shown to produce anxiolytic-like actions, arousal, and enhance memory consolidation, whereas blockade of the NPSR has been shown to reduce relapse to substances of abuse and duration of anesthetics. We report here the discovery of a novel core scaffold (+) N-benzyl-3-(2-methylpropyl)-1-oxo-3-phenyl-1H,3H,4H,5H,6H,7H-furo[3,4-c]pyridine-5-carboxamide with potent NPSR antagonist activity in vitro. Pharmacokinetic parameters demonstrate that 14b reaches pharmacologically relevant levels in plasma and the brain following intraperitoneal (i.p.) administration, but is cleared rapidly from plasma. Compound 14b was able to block NPS (0.3 nmol)-stimulated locomotor activity in C57/Bl6 mice at 3 mg/kg (i.p.), indicating potent in vivo activity for the structural class. This suggests that 14b can serve as a useful tool for continued mapping of the pharmacological functions of the NPS receptor system.